Could oxytocin reduce autoimmune disease in COVID-19?

Phuoc-Tan Diep; Véronique de Kok

doi:https://doi.org/10.1016/j.autrev.2021.102994

doi.org/10.1016/j.autrev.2021.102994

Could oxytocin reduce autoimmune disease in COVID-19?

,

Autoimmunity Reviews13.60

Volume: 21, Issue: 2, Pages: 102994 - 102994

Published: Feb 1, 2022

Abstract

Disruption of immune and neuroendocrine system function has been shown to play a key role in COVID-19. Oxytocin is vitally important for the immune and neuroendocrine systems. However, oxytocin dysfunction might occur in COVID-19 leading to autoimmune disease. Intranasal oxytocin may be effective in turning off an overactive immune system. This could be a powerful approach to avoid possible autoimmune diseases after...